What to look forward to in GaBI Journal, 2014, Issue 2
Complex molecules – current developments
Clinical development, immunogenicity, and interchangeability of follow-on complex drugs
Tyrosine kinase inhibitors becoming generic drugs – risks and chances from a regulatory perspective
Interchangeability. An insurmountable fifth hurdle?
Role of hospital clinical pharmacist in transplantation, and generic immunosuppressive therapies
Weighing up the cost of switching to biosimilars
Source URL: https://gabi-journal.net/20142-gabi-journal-table-of-contents.html
Copyright ©2024 GaBI Journal unless otherwise noted.